Ascendis Health バランスシートの健全性

財務の健全性基準チェック /56

Ascendis Healthの総株主資本はZAR618.3M 、総負債はZAR4.8Mで、負債比率は0.8%となります。総資産と総負債はそれぞれZAR1.1BとZAR444.6Mです。 Ascendis Healthの EBIT はZAR7.6Mで、利息カバレッジ比率5.3です。現金および短期投資はZAR50.6Mです。

主要情報

0.8%

負債資本比率

R4.80m

負債

インタレスト・カバレッジ・レシオ	5.3x
現金	R50.63m
エクイティ	R618.27m
負債合計	R444.58m
総資産	R1.06b

財務の健全性に関する最新情報

Recent updates

There Is A Reason Ascendis Health Limited's (JSE:ASC) Price Is Undemanding

Sep 23

財務状況分析

短期負債: ASCの短期資産 ( ZAR768.5M ) が短期負債 ( ZAR408.9M ) を超えています。

長期負債: ASCの短期資産 ( ZAR768.5M ) が長期負債 ( ZAR35.7M ) を上回っています。

デット・ツー・エクイティの歴史と分析

負債レベル: ASC総負債よりも多くの現金を保有しています。

負債の削減: ASCの負債対資本比率は、過去 5 年間で294.4%から0.8%に減少しました。

債務返済能力: ASCの営業キャッシュフローはマイナスであるため、負債は十分にカバーされていません。

インタレストカバレッジ: ASCの負債に対する利息支払いは EBIT ( 5.3 x coverage) によって十分にカバーされています。

Ascendis Health バランスシートの健全性

財務の健全性 基準チェック /56

主要情報

財務の健全性に関する最新情報

Ascendis Health To Delist from JSE, Upon Deal Goes Through

Ascendis Considers Delisting from JSE

Ascendis Health Limited Auditor Raises 'Going Concern' Doubt

Recent updates

Ascendis Health Limited, Annual General Meeting, Nov 29, 2024

An undisclosed buyer acquired an unknown minority stake in Ascendis Health Limited (JSE:ASC) from Alpvest Equities Proprietary Limited.

Ascendis Health Limited to Report Fiscal Year 2024 Results on Sep 03, 2024

Ascendis Health Limited to Report First Half, 2024 Results on Mar 28, 2024

Ascendis Health Limited Announces Lawrence Mulaudzi Not Available for Re-Election as Director

Ascendis Health Limited, Annual General Meeting, Nov 30, 2023

Ascendis Health To Delist from JSE, Upon Deal Goes Through

Ascendis Health Limited Appoints Joseph Fine as Company Secretary

Ascendis Health Limited to Report Fiscal Year 2023 Results on Sep 29, 2023

There Is A Reason Ascendis Health Limited's (JSE:ASC) Price Is Undemanding

High number of new and inexperienced directors

Ascendis Health Limited, Annual General Meeting, Nov 30, 2022

Ascendis Health Limited, Annual General Meeting, Nov 30, 2022

Ascendis Health Limited to Report Fiscal Year 2022 Results on Sep 28, 2022

Ascendis Health Limited Announces Board Changes

Ascendis Considers Delisting from JSE

Kefolile Health Investments Pty Ltd acquired an unknown minority interest in Ascendis Health Limited (JSE:ASC)

MMC International Health Holding S.L entered into sale of shares agreement to acquire Farmalider, S.A. from Ascendis Health Limited (JSE:ASC) for €5 million.

The management of Respiratory Care Africa (Pty) Ltd. agreed to acquire Respiratory Care Africa (Pty) Ltd. from Ascendis Health Limited (JSE:ASC) in a management buyout transaction.

First half 2021 earnings released: R0.63 loss per share (vs R0.16 profit in 1H 2020)

Independent Non-Executive Director has left the company

Ascendis Health Limited Announces Resignation of Yoza Jekwa, with Effect from 11 March 2021

Ascendis Health Limited to Report First Half, 2021 Results on Mar 31, 2021

New 90-day low: R0.66

An unknown buyer acquired an unknown minority stake in Ascendis Health Limited (JSE:ASC) from Public Investment Corporation Limited.

Ascendis Health Limited Approves Board Changes

New 90-day high: R0.81

Full year 2020 earnings released: R1.74 loss per share

Ascendis Health Limited Announces the Changes to Board Committees

New 90-day low: R0.56

Mary Bomela Resigns as Independent Non-Executive Director of Ascendis Health Limited with Effect from 31 October 2020

Ascendis Health Announces the Appointment of Cheryl-Jane (CJ) Kujenga as Chief Financial Officer, Effective 1 December 2020

Ascendis Health Limited Auditor Raises 'Going Concern' Doubt

New 90-day low: R0.58

Full year earnings released - R1.74 loss per share

Austell Pharmaceuticals Proprietary Limited agreed to acquire Dezzo Trading 392 Proprietary Limited from Ascendis Health Limited (JSE:ASC) for ZAR 80 million.

New 90-day low - R0.78

Ascendis Health Limited(JSE:ASC) dropped from S&P Global BMI Index

財務状況分析

デット・ツー・エクイティの歴史と分析

貸借対照表

健全な企業の発掘

財務の健全性基準チェック /56